Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study

• Status: Suspended
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This registry aims to monitor the safety of Breviscapine Powder-Injection and to identify the potential risk factors for the adverse drug reactions.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Zhong Wang

Criteria

Inclusion Criteria:

• Patients who use Breviscapine Powder-Injection in the monitoring departments of centain hospitals

Exclusion Criteria:

• None